Lihao Meng

2.1k citations
12 papers · 1.7k indexed · 2 hit papers · h-index 10

Impact in

  • Oncology top 5%
    • Peptidase Inhibition and Analysis
    • Ubiquitin and proteasome pathways
    • Protein Degradation and Inhibitors
    • Signaling Pathways in Disease
    • Chemical Synthesis and Analysis

Papers in

Lihao Meng

12 papers receiving 1.7k citations

Hit Papers

Epoxomicin, a potent and selective proteasome inhibitor, exhibitsin vivoantiinflammatory activity 1999 · 803 citations
8031997202620062016250500750

Peers

Lihao Meng
Comparison fields: 5 of 92
  • Oncology 645
  • Molecular Biology 1.3k
  • Cancer Research 207
  • Cellular and Molecular Neuroscience 236
  • Cell Biology 203
Replace Bernd Gerhartz with:
Bernd Gerhartz Switzerland
Luc G. Berthiaume Canada
Greg Finn United States
Xiang-Jiao Yang Canada
J. Fraser Glickman United States
Charlene Michaud United States
Koji Sagane Japan
Lucy Ghoda United States
Tomoko Masuda Japan
Ian G. Cowell United Kingdom
Lihao Meng relative to Bernd Gerhartz Switzerland Bernd Gerhartz's profile →
Citations per field
00.5×1.5×2.4×
Bernd Gerhartz · 1×
Citations per year

Countries citing papers authored by Lihao Meng

Since Specialization
Citations

This map shows the geographic impact of Lihao Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lihao Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lihao Meng more than expected).

Fields of papers citing papers by Lihao Meng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lihao Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lihao Meng. The network helps show where Lihao Meng may publish in the future.

Co-authorship network

The 22 scholars most cited alongside Lihao Meng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lihao Meng Line = papers co-authored together Lihao Meng links everyone, so they are left out of the graph.

All Works

12 of 12 papers shown
#Work
1 20219
2 20121
3 201014
4 20091
5 200821
6 1999164
7
Epoxomicin, a potent and selective proteasome inhibitor, exhibitsin vivoantiinflammatory activity
Hit paper breakdown →
1999803
8 199850
9 199831
10
The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2
Hit paper breakdown →
1997530
11 199641
12 199571

About Lihao Meng

Lihao Meng is a scholar working on Cancer Research, Oncology, Radiology, Nuclear Medicine and Imaging, Molecular Biology and Cellular and Molecular Neuroscience, having authored 12 papers that have together received 1.7k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (5 papers), Advanced Biosensing Techniques and Applications (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Advanced biosensing and bioanalysis techniques (3 papers), Signaling Pathways in Disease (2 papers), Ubiquitin and proteasome pathways (2 papers), Neuroscience and Neuropharmacology Research (2 papers) and Synthesis and Biological Activity (1 paper). The work is most often cited by research in Oncology (645 citations), Molecular Biology (1.3k citations), Cancer Research (207 citations), Cellular and Molecular Neuroscience (236 citations) and Cell Biology (203 citations). Lihao Meng has collaborated with scholars based in United States and China. Frequent co-authors include Ny Sin, Craig M. Crews, Mikael Elofsson, Benjamin H. Kwok, Royce Mohan, James Wen, William G. Bornmann, Erik Floor, Kyung Bo Kim and Weiqing Chen. Their work appears in journals such as Proceedings of the National Academy of Sciences, Bioorganic & Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Biochemistry and BMC Biotechnology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026